International Study Support Biotron's HIV Drug Approach
Excerpts:
"An independent, international published study has provided strong support for Biotron Limited's ('Biotron') HIV drug development program. The study demonstrated how the deadly HIV virus manages to avoid the human body's natural defence mechanisms, showing that the Vpu protein of HIV is central to this process.
Biotron has a first-in-class drug that specifically targets the Vpu protein of HIV"
"We have been leading the way into the clinic with this new class of drug and to see studies like this from the scientific community underlines the importance of Biotron's HIV program"
Stirred up a little interest now.
- Forums
- ASX - By Stock
- BIT
- a cure for hep c, aids, the flu and dengue...
a cure for hep c, aids, the flu and dengue..., page-87
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.001(5.56%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.8¢ | 1.9¢ | 1.8¢ | $3.69K | 197.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2175000 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 480522 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2175000 | 0.017 |
11 | 2337904 | 0.016 |
16 | 2996688 | 0.015 |
7 | 5758433 | 0.014 |
5 | 1849000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 480522 | 6 |
0.020 | 1094211 | 7 |
0.021 | 600000 | 1 |
0.022 | 340866 | 2 |
0.023 | 508000 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online